Lab Members

Dr. Plon’s translational research has focused on analysis of patients with inherited susceptibility to childhood cancer, for example Rothmund Thomson syndrome associated with mutations in the RECQL4 gene and predisposition to osteosarcoma. Over the last ten years her research group has also reported on novel mechanisms of AML predisposition (microdeletion of 21q22), a novel chromosome breakage syndrome (LICS) and enrolling and interrogating the constitutional genome in families with unusual patterns of childhood cancer and congenital anomalies through whole genome and exome sequencing.

Ms. Scollon's research interests include pediatric cancer predisposition syndromes and educating healthcare providers in recognizing at risk patients and families in order to provide families education, advocacy, and increase the adoption of prevention and screening for future cancers. She also has conducted research involving the incorporation of genomic sequencing into clinical care.

Her ongoing research will look into the incorporation of genetic counseling into precision oncology. Themes included in Ms. Scollon’s research include: